Publications
- Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidlines related to the diagnostics and treatment of dyslipidemias issued in 2011 +32013 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The effect of high density lipoprotein on atherogenesis and increase in its concentration induced by CETP inhibiton2010 | First Faculty of Medicine
- Ivabradin, heart rate and cardiovascular risk. A commentary on the BEAUTIFUL trial2009 | First Faculty of Medicine
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
- Statement CSAT on Consensus statement of the European Atherosclerosis Society: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- ČSAT opinion on the EAS 2021 Consensus: Lipoproteins rich in triglycerides and their remnant particles - overview of metabolism, role in atherosclerotic cardiovascular disease and new therapeutic strategies2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
- Interna2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Genetic testing of familial hypercholesterolemia in clinical practice: statement of Czech Society for Atherosclerosis2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Genetické testování familiární hypercholesterol-emie v klinické praxi: stanovisko výboru České společnosti pro aterosklerózu2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Therapy with drugs containing the active ingredient LOMITAPIDE in patients with homozygous form of familial hypercholesterolemia: a statement of the committee of the Czech Society for Atherosclerosis2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...